These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Isolation and characteristics of the "direct" hemolytic factor in the venom of the Central Asian cobra]. Iukel'son LIa; Sadykov E; Sorokin VM Biokhimiia; 1974; 39(4):816-21. PubMed ID: 4441571 [No Abstract] [Full Text] [Related]
26. Analysis of camelid antibodies for antivenom development: Neutralisation of venom-induced pathology. Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA Toxicon; 2010 Sep; 56(3):373-80. PubMed ID: 20412814 [TBL] [Abstract][Full Text] [Related]
27. IMMUNOCHEMICAL STUDIES OF SNAKE VENOM. I. PAPER ELECTROPHORETIC PATTERNS AND PRECIPITIN REACTIONS OF ANTI-COBRA SERA. CHANG CC; YANG CC Tsa Chih Gaoxiong Yi Xue Yuan Tong Xue Hui; 1964 Oct; 63():455-66. PubMed ID: 14246517 [No Abstract] [Full Text] [Related]
29. Catalytic properties of two phospholipases A from cobra (Naja nigricollis) venom. Dupont J Toxicon; 1977; 15(4):347-54. PubMed ID: 18817 [No Abstract] [Full Text] [Related]
30. Biologically active components of cobra venom in relation to cancer research. Braganca BM Indian J Med Res; 1976 Aug; 64(8):1197-207. PubMed ID: 992850 [No Abstract] [Full Text] [Related]
31. [Neurotoxins in snake venoms (author's transl)]. Hayashi K; Ota M Tanpakushitsu Kakusan Koso; 1975 Jan; 20(1):53-69. PubMed ID: 124448 [No Abstract] [Full Text] [Related]
32. Resolution of the main hemorrhagic principle of Trimeresurus flavoviridis venom into two parts, HRIA and HRIB [proceedings]. Omori-satoh T; Sadahiro S Jpn J Med Sci Biol; 1978 Apr; 31(2):205. PubMed ID: 682382 [No Abstract] [Full Text] [Related]
33. The primary structure of toxin B from the venom of the Indian cobra Naja naja. Ohta M; Sasaki T; Hayashi K FEBS Lett; 1976 Nov; 72(1):161-6. PubMed ID: 992083 [No Abstract] [Full Text] [Related]
34. Development of snake antivenom antibodies in chickens and their purification from yolk. Almeida CM; Kanashiro MM; Rangel Filho FB; Mata MF; Kipnis TL; da Silva WD Vet Rec; 1998 Nov; 143(21):579-84. PubMed ID: 9854769 [TBL] [Abstract][Full Text] [Related]
36. Interrelation between two anticomplement cobra venom factors isolated from crude Naja naja cobra venom. Johnson BJ; Kucich UN J Pharm Sci; 1977 Jul; 66(7):947-9. PubMed ID: 886456 [TBL] [Abstract][Full Text] [Related]
37. Timeline of key events in snake venom metalloproteinase research. Fox JW; Serrano SM J Proteomics; 2009 Mar; 72(2):200-9. PubMed ID: 19344655 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of health status of horses immunized with snake venom and montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (emulsion based) during polyvalent snake antivenom production: hematological and biochemical assessment. Waghmare AB; Salvi NC; Deopurkar RL; Shenoy PA; Sonpetkar JM Toxicon; 2014 May; 82():83-92. PubMed ID: 24582735 [TBL] [Abstract][Full Text] [Related]
39. [Acetylcholinesterase of cobra venom. Determination of concentration of active sites]. Iarv IaL; Aaviksaar AA; Godovikov NN; Langel' IuL; Past UE Biokhimiia; 1976 May; 41(5):827-35. PubMed ID: 1030638 [TBL] [Abstract][Full Text] [Related]
40. Mitochondrial DNA sequences from dried snake venom: a DNA barcoding approach to the identification of venom samples. Pook CE; McEwing R Toxicon; 2005 Dec; 46(7):711-5. PubMed ID: 16157361 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]